Related Experiment Video
Updated: Feb 1, 2026

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review
Zhu You1,2,3, Shao-Peng Liu1,2, Jing Du1,4
1Shandong Provincial Key Laboratory of Oral Tissue Regeneration, School of Stomatology, Shandong University, Jinan, Shandong Province, China.
Abstract:
Numerous signal transduction pathways are closely associated with the occurrence, development, and prognosis of ameloblastoma (AM). Mitogen-activated protein kinase (MAPK) is a serine/threonine-specific protein kinase that transduces intracellular signals in critical cellular phenomena. A number of recent analyses have reported that the MAPK signaling pathway contributes significantly to AM. High-throughput DNA sequencing methods, such as next-generation sequencing using Illumina have yielded advancements in studies on MAPK signaling pathways and their association with AM; in particular, BRAF V600E is mediated by the activation of the Ras/Raf/MAPK pathway. This review discusses advancements in studies on MAPK signaling pathways and MAPK-targeted inhibitors or antibodies, along with the merits and demerits of MAPK-targeted therapies, finally followed by a discussion regarding more efficient potential MAPK-targeted therapies to treat AM with few side effects, thereby providing novel insights into targeted therapy for AM.
Insights
Mitogen-activated protein kinase (MAPK) pathways are crucial in ameloblastoma (AM) development. This review explores MAPK-targeted therapies for AM, discussing current treatments and future directions for improved efficacy and reduced side effects.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ameloblastoma (AM) development and prognosis are linked to various signal transduction pathways.
- Mitogen-activated protein kinase (MAPK) signaling is a critical pathway involved in cellular processes and has been implicated in AM.
Purpose of the Study:
- To review advancements in understanding MAPK signaling pathways in ameloblastoma.
- To discuss current and potential MAPK-targeted therapies for AM, including their benefits and drawbacks.
Main Methods:
- Literature review of studies on MAPK signaling in ameloblastoma.
- Analysis of next-generation sequencing data, particularly focusing on BRAF V600E mutations and the Ras/Raf/MAPK pathway.
- Evaluation of MAPK-targeted inhibitors and antibodies.
Main Results:
- The MAPK signaling pathway, particularly through BRAF V600E activation, plays a significant role in ameloblastoma.
- Next-generation sequencing has advanced the study of MAPK pathways in AM.
- Existing MAPK-targeted therapies have both advantages and disadvantages.
Conclusions:
- Targeted therapies focusing on the MAPK pathway show promise for ameloblastoma treatment.
- Further research is needed to develop more efficient MAPK-targeted therapies with fewer side effects for AM.
Related Concept Videos
MAPK Signaling Cascades
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Non-Canonical Wnt Signaling Pathways

